1. Low disease activity
2. Low disease activity outweigh current drugs in the market - in other words, working better than any drug on the market
3. Improvement maintained, at this stage, for 39 weeks, likely to continue to week 50.
Don't worry about the negativity. These results are amazing and there will be a massive deal done very shortly, around the corner, bigger than the original Cephalon deal.
Awesome results. the share price is going to sky rocket soon, and i wouldn't even bother with $15, it will be multiples of this.
Hottuna and Madamswear you really do make me laugh. have a great day you two.
Fantastic
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.05 |
Change
0.078(7.99%) |
Mkt cap ! $1.196B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.06 | 99.0¢ | $3.867M | 3.762M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 89776 | $1.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.05 | 115841 | 18 |
View Market Depth
| Last trade - 14.45pm 04/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |